Skip to main content
. 2021 Jul 27;11:637247. doi: 10.3389/fonc.2021.637247

Figure 3.

Figure 3

SMAD2 is a direct target of exosomal miR-125b in recipient HCC cells. (A) Two potential seed regions (gray) indicate the binding site of miR-125b in SMAD2 3′ UTR. (B) Western blot assay showing decreased protein expression of SMAD2 after treatment with Exo-125b compared to that after treatment with Exo-NC. (C) Statistical analysis of SMAD2 protein expression in recipient HCC cells. Data are presented as mean ± SEM. *p < 0.05 vs. Exo-NC.